Investor Presentaiton

Figure 1: Other states, but not Oregon, have passed laws requiring PBMs to report information² AK HI WA MT ND MN WI MI WY SD ΙΑ ME VT NH NY MA RI IN OH PA NJ CT OR NV CO NE MO KY WV VA MD DE UT NM KS AR TN NC SC DC AZ OK LA MS SS TX AL GA FL PBM reporting requirements Source: National Council of State Legislatures Many of Oregon's efforts to lower prescription drug costs have been targeted at drug manufacturers and not PBMs. To better understand this complex and often opaque system, policymakers should have information available to them to make informed decisions and help determine whether PBMs and other key players are providing benefits and delivering good value to Oregonians. Figure 2 details some of the requirements for which 16 other states require their PBMS to submit information. Figure 2: Rebates, administrative fees, and spread pricing are common elements reported in other states OR CT GA IN IA LA MI MN MT NV ΝΗ NY TX UT VT VA WI Drug rebates from drug manufacturers or other sources Drug rebates passed though and/or retained Admin fees from health plans Admin fees from pharmacies Admin fees from drug manufacturers All admin fees retained Spread pricing retained Data collection Public reporting (in aggregate) Source: National Council of State Legislatures 2 Note this figure differs from the map in the letter sent to Representative Nathanson in September 2022. The previous map included other transparency measures adopted by states that are not reflected in the map above, which only includes PBM reporting requirements. See the National Conference of State Legislatures website for more information. Oregon Secretary of State | February 2023 | page 2

View entire presentation